Synergistic Reduction of Radiation Exposure in FEVAR: Early Monocentric Outcomes Using the BeFlared Bridging Stent Using an Ultra-Low Dose (ULD) Protocol
Clicks: 2
ID: 315750
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.3
/100
2 views
1 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #167 of 432 articles by views in the british journal of surgery
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 432 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Background Fenestrated and Branched endovascular aneurysm repair (f/bEVAR) is a technically demanding procedure associated with high fluoroscopy times and significant radiation exposure for both the patient and the operating team. Aims This study aimed to evaluate the early clinical outcomes and radiological efficiency of the new BeFlared bridging stent (Bentley, Hechingen, Germany)—which enables stent deployment and flaring in a single step using a step-balloon —in combination with the institutional "Ultra Low-Dose EVAR" protocol in use at our institution (Luzerner Kantonsspital). Methods This monocentric observational study included 15 consecutive patients treated by FEVAR. All procedures were performed using the BeFlared bridging stent. A dedicated Ultra-Low-Dose Protocol was applied in all cases, utilizing 2D-3D fusion imaging and optimal collimation to minimize exposure. Primary endpoints were technical success, early safety, and radiological parameters including Dose Area Product (DAP) and fluoroscopy time. Results Technical success was 100%. The single-step deployment mechanism of the BeFlared stent contributed, in conjuction with the Ulta-Low-Dose Protocol,to lower the median DAP. Stent-related re-interventions were not observed within the first 6 weeks. Conclusion The combination of the novel BeFlared bridging stent and a dedicated Ultra-Low-Dose Protocol proved to be safe and effective in this monocentric series (n=15). The simplified handling of the stent appears to act synergistically with radiation-sparing measures, leading to a relevant reduction in radiation exposure. Larger cohorts are required to confirm these observations.
| Reference Key |
openalex_W7163395941
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | M Di Mauro, M Hakimi, G Jung, N Attigah |
| Journal | the british journal of surgery |
| Year | 2026 |
| DOI |
10.1093/bjs/znag055.078
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.